Fungal infections of the central nervous system (CNS) are uncommon. Despite several advancements in diagnosis and treatment of these infections, the mortality rates remain high. The current retrospective study was planned to define the demographic and clinical features of patients with CNS fungal infections. Conducted at Aga Khan University Hospital, Karachi, and comprising CNS fungal infections operated between January 2000 and December 2015. The study analysed whether a short course of pre-operative anti-fungal therapy may improve outcomes in these patients. There were 47 cases confirmed on histopathology and/or microbiology. Outcome measures used were Glasgow coma score (GCS), Glasgow outcome score (GOS) and Karnofsky performance score (KPS). The overall 30-day mortality was 20(42.5%). Fungal infections of the CNS can occur in both immune-compromised and immune-competent patients. Early diagnosis, radical surgery, pre-operative anti-fungal therapy for at least 2 weeks, pre- and postoperative Voriconazole therapy results in more favourable outcomes.
JPMA. The Journal of the Pakistan Medical Association
Khan, M. F.,
(2019). Pre-operative voriconazole in patients undergoing surgery for central nervous system fungal infections: Special report. JPMA. The Journal of the Pakistan Medical Association, 69(1), 103-107.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/175
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License